Home > Boards > US Listed > Biotechs >

Bristol-Myers (BMY)

BMY RSS Feed
Add BMY Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board: 
Last Post: 9/29/2019 12:57:25 PM - Followers: 32 - Board type: Free - Posts Today: 0
BMY
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BMY News: Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes 10/08/2019 06:59:00 AM
BMY News: Opdivo (nivolumab) Demonstrates Statistically Significant Overall Survival Benefit Versus Chemotherapy in Patients with Advan... 09/30/2019 10:30:00 AM
BMY News: Bristol-Myers Squibb Announces Final Results from CheckMate -227 Part 1 Demonstrating Superior Overall Survival for Opdivo (n... 09/28/2019 10:30:00 AM
BMY News: Adjuvant Treatment with Opdivo (nivolumab) Continues to Demonstrate Extended Recurrence-Free Survival at Three Years in Resec... 09/28/2019 02:30:00 AM
BMY News: Five-Year Outcomes for Opdivo (nivolumab) in Combination with Yervoy (ipilimumab) Demonstrate Durable Long-Term Survival Bene... 09/28/2019 02:30:00 AM
PostSubject
#873   BMY’s ESMO slide set: DewDiligence 09/29/19 12:57:25 PM
#872   BMY ESMO lineup includes talks on how to DewDiligence 09/19/19 09:42:59 AM
#871   BMY/CELG sell Otezla to AMGN for $13.4B in cash: DewDiligence 08/26/19 10:36:28 AM
#870   Insider buy—($500K)—by relatively new director: DewDiligence 08/01/19 05:15:11 PM
#869   Maybe now we’ll see a nice run into Spumoni 07/26/19 03:21:53 PM
#868   News: $BMY Bristol-Myers Squibb Receives Positive CHMP Opinion whytestocks 07/26/19 08:10:28 AM
#867   BMY 2Q19 CC transcript: DewDiligence 07/25/19 06:47:50 PM
#866   Eliquis is now selling at an annualized rate DewDiligence 07/25/19 10:18:44 AM
#865   The 10% revenue increase was impressive. biotech_researcher 07/25/19 08:31:14 AM
#864   BMY 2Q19 results: DewDiligence 07/25/19 08:17:00 AM
#863   More details on Part 2 of CHECKMATE-227 in DewDiligence 07/24/19 05:31:55 PM
#862   More CHECKMATE-227 results—not exactly bullish: DewDiligence 07/24/19 04:36:39 PM
#861   BMY opens every trading day and continues to biotech_researcher 07/22/19 10:26:42 AM
#860   Eliquis has US/int'l patent protection until 2026 (#msg-149837229). DewDiligence 07/10/19 01:54:36 PM
#859   FDA tentatively approves Mylan's generic Eliquis • The biotech_researcher 07/10/19 12:58:55 PM
#858   July 13, 2013 was the last time BMY biotech_researcher 07/05/19 09:20:53 AM
#857   Think they missed the issues biotech_researcher 06/24/19 11:41:41 AM
#856   BMY’s CHECKMATE-459 study testing Opdivo-vs-Nexavar in 1L-HCC fails DewDiligence 06/24/19 09:34:36 AM
#855   BMY will divest CELG’s Otezla to satisfy FTC—merger DewDiligence 06/24/19 09:27:07 AM
#854   Ozanimod PDUFA date in RMS is 3/20/20; EMA DewDiligence 06/06/19 12:01:25 PM
#853   More color on the management changes: DewDiligence 06/05/19 12:16:36 PM
#852   BMY’s post-merger management team: DewDiligence 06/05/19 11:46:37 AM
#851   BMY independent director bought ~$240K of stock on DewDiligence 05/20/19 04:51:56 PM
#850   Dana-Farber Cancer Institute may be entitled to royalties DewDiligence 05/17/19 04:36:34 PM
#849   CHECKMATE-498 in GBS fails to show OS benefit DewDiligence 05/09/19 10:21:48 AM
#848   Typo: $19M should be $19B. DewDiligence 05/08/19 03:35:04 PM
#847   The executive in question was most recently at DewDiligence 05/08/19 03:18:05 PM
#846   Bioxytran Inc. Announces Appointment of Ex Bristol-Myers Squibb ProfitScout 05/08/19 02:51:49 PM
#845   BMY sells $19M of debt to (partially) fund DewDiligence 05/08/19 10:51:13 AM
#844   Bristol Myers ready for a BULLISH move TopMarketGainers 05/03/19 08:15:12 PM
#843   The BCMA frenzy: Tracking the 37 drugs around biotech_researcher 05/02/19 07:53:39 AM
#842   CELG 1Q19 results: DewDiligence 04/25/19 04:41:45 PM
#841   BMY 1Q19 CC transcript: DewDiligence 04/25/19 03:28:51 PM
#840   Another one of Bristol-Myers’ PD-1/CTLA-4 combo studies bites biotech_researcher 04/25/19 10:35:37 AM
#839   BMY 1Q19 results: DewDiligence 04/25/19 09:49:07 AM
#838   https://www.statnews.com/2019/04/12/bristol-myers-squibb-celgene-challenges-ahea biotech_researcher 04/17/19 05:34:40 AM
#837   where do you think its headed now Created1 04/16/19 11:50:25 PM
#836   That was quick.. Sold all BMY biotech_researcher 04/16/19 11:46:50 AM
#835   Jeff Smith, CEO from Starboard just stated on biotech_researcher 04/16/19 10:36:53 AM
#834   The Bristol-Celgene merger is approved. Here are 8 biotech_researcher 04/16/19 08:02:10 AM
#833   Thanks Dew for the correction.. I don’t see biotech_researcher 04/15/19 10:14:06 PM
#832   The CELG acquisition hasn't closed yet, but shareholders DewDiligence 04/15/19 09:04:20 PM
#831   I finally bought a good size chunk of biotech_researcher 04/15/19 07:34:57 PM
#830   And they are punishing BMY stock as they should.. biotech_researcher 04/12/19 12:53:13 PM
#829   Shareholders approve BMY-CELG merger: DewDiligence 04/12/19 11:08:41 AM
#828   This deal is getting heavy protest. BMY should Biotech Pharmer 03/15/19 11:53:36 AM
#827   This may give the deal pause: https://endpts.com/one-of-the-top-late-stage-drugs biotech_researcher 03/13/19 12:50:33 PM
#826   Doubt a few groups will stop the deal, Johnny_C 03/04/19 07:17:11 AM
#825   Doesnt seem BMY shareholders like the deal Johnny_C 02/28/19 04:29:43 PM
#824   Bloomberg piece in favor of CELG deal: DewDiligence 02/28/19 04:09:24 PM
PostSubject